Clinical Trial Update: A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) [Phase 2]

View source ↗

Summary

Phase 2 trial of nivolumab in relapsed/refractory primary CNS lymphoma and primary testicular lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma
• Lymphoma
• Testicular Lymphoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2020-10-28